Ambiq Wins 2025 Global Company of the Year Award for Healthcare Semiconductor Innovation

Ambiq’s Achievement in Healthcare Semiconductor Solutions

Image Credits: Ambiq

Semiconductor in the Healthcare Industry

Semiconductors play a significant role in healthcare by providing advancement and development in technologies and the medical devices market. It is a major component for several diagnostic tools. The healthcare market is advancing with semiconductor solutions. One more addition to the advancement is the recent Ambiq’s contribution. Frost and Sullivan proudly announced that Ambiq has received an award for the Global Company of the Year 2025 in the semiconductor solutions category for healthcare companies. Ambiq’s commendable progress in technology advancement, customer-centric strategy, and innovation paved the way for this award. This achievement on the global platform represents Ambiq’s persistence and advanced leadership in discovering ultra-low-power semiconductor platforms are enabling transitional change in digital health solutions.

Innovation

Innovation is a primary approach of Ambiq. Its Apollo system-on-chip series is still in demand and is building a remarkable presence by focusing on energy efficiency to accelerate smart health devices. The popular Apollo510 merges a Cortex-M55 CPU with helium technology and security features such as ARM TrustZone and secureSPOT with PUF and excellent graphic performance through its 2.5D GPU. The company is focusing on introducing variations of current and next-gen Apollo SOCs to attract customers and provide AI-enabled devices.

Frost and Sullivan’s Evaluation Process

The evaluation of companies is conducted carefully with the two main dimensions, such as strategy execution and strategy effectiveness. Ambiq withstands these dimensions by highlighting its consistency, ability. The company also introduced cutting-edge products and its timely delivery. The product improves scalability, performance, and energy efficiency in healthcare and other suitable sectors. Frost and Sullivan’s prestigious awards are given to the forward-thinking organizations that redesign their respective industries with innovation.

Views and Statements

The industry analyst at Frost and Sullivan, Utkarsha Soundankar, said, “Ambiq’s major approach is to provide energy-efficient solutions with extended battery life. The company is also initiating models or solutions for AI that can provide more convenient availability of ultra-low power edge AI technologies.”

CEO of Ambiq, Fumihide Esaka, said, “The company is privileged to receive a prestigious Frost and Sullivan award in healthcare semiconductor solutions. Additionally, the company has always been on a mission to provide intelligence to all sectors, most probably to our digital health customers. To enable healthcare accessibility to everyone is a main mission. Ambiq feels proud to be able to serve healthcare innovators, which is contributing to patient care with our low-cost ultra-low power semiconductors and solutions.”